Hexagon Capital Partners’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-139
Closed -$14.7K – 1070
2025
Q1
$14.7K Sell
139
-29
-17% -$2.99K ﹤0.01% 853
2024
Q4
$16.2K Sell
168
-81
-33% -$8.07K ﹤0.01% 860
2024
Q3
$24.6K Sell
249
-119
-32% -$10.9K ﹤0.01% 637
2024
Q2
$31.6K Buy
368
+32
+10% +$2.52K 0.01% 543
2024
Q1
$25.5K Buy
336
+45
+15% +$3.47K 0.01% 606
2023
Q4
$22.1K Buy
291
+208
+251% +$14.5K 0.01% 602
2023
Q3
$5.73K Buy
83
+24
+41% +$1.73K ﹤0.01% 884
2023
Q2
$4.93K Sell
59
-33
-36% -$2.68K ﹤0.01% 901
2023
Q1
$6.8K Sell
92
-4
-4% -$281 ﹤0.01% 829
2022
Q4
$6.78K Buy
96
+22
+30% +$1.47K ﹤0.01% 833
2022
Q3
$4K Buy
+74
New +$4.26K ﹤0.01% 974

Other funds holding MMSI

Hexagon Capital Partners's MMSI Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Merit Medical Systems (MMSI) in Q2 2025, closing a stake of 139 shares — an estimated $14.7K sold.

Hexagon Capital Partners first reported a position in MMSI in Q3 2022 and held it in 11 quarters. The position peaked at $31.6K in Q2 2024. 379 funds tracked by Wall St. Rank hold MMSI as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Merit Medical Systems position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 139 Merit Medical Systems shares in Q2 2025, an estimated $14.7K.
  • Hexagon Capital Partners first reported a position in Merit Medical Systems in Q3 2022 and held it in 11 quarters.
  • Hexagon Capital Partners's Merit Medical Systems position peaked at $31.6K in Q2 2024.
  • 379 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.